The United States government will pay vaccine manufacturer Moderna $176 million to develop a new mRNA vaccine to treat bird flu. The U.S. Department of Health and Human Services will pay Moderna $176 million for a vaccine containing the same mRNA technology as the company’s COVID-19 vaccine. ... Moderna will launch trials to test the safety and effectiveness of a vaccine that could be used to scale up a response to a bird flu pandemic if needed.